Skip to content

Ardelyx ARDX Interest Expense

Interest Expense at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$402M+21.8%
XER
Xeris Biopharma Holdings, Inc.XERS
$6.88M-5.8%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
-$840K+18.3%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$1.01M-5.2%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$6M+168%
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's interest expense?
Ardelyx (ARDX) reported interest expense of $5.6M in Q1 2026.
How has Ardelyx's interest expense changed year-over-year?
Ardelyx's interest expense increased by 33.6% year-over-year, from $4.19M to $5.6M.
What is the long-term trend for Ardelyx's interest expense?
Over 4 years (2021 to 2025), Ardelyx's interest expense has grown at a 45.4% compound annual growth rate (CAGR), from $4.5M to $20.1M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.